Washington Growth Strategies LLC reported 21 positions worth $16.45M for the quarter ended Sep 30, 2026, up 3.7% on the prior quarter. It opened 0 new positions, added to 0, trimmed 0 and exited 0. Its largest holding is Opko Health, Inc. at 13.3% of the portfolio.
Reported 13F market value at each quarter end. A change mixes trading with price moves in the positions held.
Dollar value of shares bought and sold each quarter, at that quarter’s price. It counts trading only, not price changes.
How many positions were opened, added to, trimmed or closed each quarter.
Share of reported value in each sector at every quarter end.
No positions were added to this quarter.
No positions were reduced this quarter.
No new positions this quarter.
No positions were closed this quarter.
| # | Activity | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | OPK Opko Health, Inc. | Healthcare | 1.36M | $2.18M | 13.27% | 0 | 0.0% | Unchanged | 0.18% |
| 2 | AMZN Amazon Com Inc | Consumer Discretionary | 7,655 | $1.91M | 11.6% | 0 | 0.0% | Unchanged | 0% |
| 3 | BAC Bank Of America Corp | Financial Services | 32.7K | $1.78M | 10.84% | 0 | 0.0% | Unchanged | 0% |
| 4 | CTRE CareTrust REIT, Inc. | Real Estate | 40.7K | $1.49M | 9.05% | 0 | 0.0% | Unchanged | 0.02% |
| 5 | ABBV AbbVie Inc. | Healthcare | 4,299 | $1.12M | 6.84% | 0 | 0.0% | Unchanged | 0% |
| 6 | GOOGL Alphabet Inc. | Technology | 3,208 | $1.10M | 6.71% | 0 | 0.0% | Unchanged | 0% |
| 7 | NVDA Nvidia Corp | Technology | 4,526 | $1.03M | 6.28% | 0 | 0.0% | Unchanged | 0% |
| 8 | AAPL Apple Inc. | Technology | 2,859 | $952.11K | 5.79% | 0 | 0.0% | Unchanged | 0% |
| 9 | TMO Thermo Fisher Scientific Inc. | Healthcare | 842 | $568.39K | 3.46% | 0 | 0.0% | Unchanged | 0% |
| 10 | VRTX Vertex Pharmaceuticals Inc / Ma | Healthcare | 998 | $521.77K | 3.17% | 0 | 0.0% | Unchanged | 0% |
| 11 | MMED MiniMed Group, Inc. | Healthcare | 26.6K | $517.65K | 3.15% | 0 | 0.0% | Unchanged | 0.01% |
| 12 | PLTR Palantir Technologies Inc. | Technology | 2,498 | $467.25K | 2.84% | 0 | 0.0% | Unchanged | 0% |
| 13 | GILD Gilead Sciences, Inc. | Healthcare | 3,062 | $456.39K | 2.77% | 0 | 0.0% | Unchanged | 0% |
| 14 | JNJ Johnson & Johnson | Healthcare | 1,716 | $454.29K | 2.76% | 0 | 0.0% | Unchanged | 0% |
| 15 | ENB Enbridge Inc | Energy | 9,322 | $433.38K | 2.63% | 0 | 0.0% | Unchanged | 0% |
Tip. Select a row to see that position’s full history at Washington Growth Strategies.
As of its Q3 2026 13F filing, Washington Growth Strategies LLC’s five largest positions were Opko Health, Inc. (OPK) at 13.3%, Amazon Com Inc (AMZN) at 11.6%, Bank Of America Corp (BAC) at 10.8%, CareTrust REIT, Inc. (CTRE) at 9.0%, AbbVie Inc. (ABBV) at 6.8% of the reported portfolio.
Washington Growth Strategies LLC reported a 13F portfolio worth $16.45M across 21 positions for Q3 2026. That is up 3.7% from the previous quarter.
From the Form 13F-HR reports Washington Growth Strategies LLC files with the SEC each quarter, within 45 days of quarter end. A 13F lists long positions in US-listed equities and options; it excludes short positions, cash, bonds and most non-US holdings.
13F data reflects long positions in US-listed equities and options as reported to the SEC up to 45 days after quarter end. It excludes short positions, cash, bonds and most non-US securities, so it is not a complete picture of a manager’s assets.